Your browser doesn't support javascript.
loading
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian, John P; Khan, Aliya A; Silverberg, Shonni J; Fuleihan, Ghada El-Hajj; Marcocci, Claudio; Minisola, Salvatore; Perrier, Nancy; Sitges-Serra, Antonio; Thakker, Rajesh V; Guyatt, Gordon; Mannstadt, Michael; Potts, John T; Clarke, Bart L; Brandi, Maria Luisa.
Afiliação
  • Bilezikian JP; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Khan AA; Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada.
  • Silverberg SJ; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Fuleihan GE; Calcium Metabolism and Osteoporosis Program, WHO CC for Metabolic Bone Disorders, Division of Endocrinology, American University of Beirut, Beirut, Lebanon.
  • Marcocci C; Department of Clinical and Experimental Medicine, University of Pisa, Endocrine Unit 2, University Hospital of Pisa, Pisa, Italy.
  • Minisola S; Department of Clinical, Internal, Anaesthesiologic and Cardiovascular Sciences, 'Sapienza', Rome University, Rome, Italy.
  • Perrier N; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sitges-Serra A; Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Thakker RV; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford, UK.
  • Guyatt G; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Mannstadt M; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Potts JT; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Clarke BL; Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA.
  • Brandi ML; Fondazione Italiana sulla Ricerca sulle Malattie dell'Osso (F.I.R.M.O. Foundation), Florence, Italy.
J Bone Miner Res ; 37(11): 2293-2314, 2022 11.
Article em En | MEDLINE | ID: mdl-36245251
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperparatireoidismo Primário Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Revista: J Bone Miner Res Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperparatireoidismo Primário Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Revista: J Bone Miner Res Assunto da revista: METABOLISMO / ORTOPEDIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos